2003•Zhōnghuá yàoxué zázhìRequires access

Studies on the pharmacokinetics and bioequivalence of domestic gatifloxacin capsules in healthy volunteers

Ai Shi

Open publisher page 0 citations

Abstract

OBJECTIVE To observe the bioavailability of domestic gatifloxacin capsules and imported tablets.METHOD A single oral dose of 400 mg domestic capsules or imported tablets were given to 20 healthy volunteers in a randomized crossover study. The concentrations of gatifloxacin were determined by HPLC method.RESULTS The main pharmacokinetics of the two products were as following: AUC 0~36 (31.60±5.45) and (30.37±5.74) μg·h·mL -1 , c max (3.32±0.55) and (3.37±0.50) μg·mL -1 , t max (1.65±0.37) and (1.55±0.46) h,respectively.The relative bioavailability of domestic capsules to imported tablets was (104.6± 8.6 )%.CONCLUSION There were no significant difference between the parameters of the two preparations( P 0.05).The results demonstrated that the two preparations were bioequivalent.

About this research paper

What this paper is about

OBJECTIVE To observe the bioavailability of domestic gatifloxacin capsules and imported tablets.METHOD A single oral dose of 400 mg domestic capsules or imported tablets were given to 20 healthy volunteers in a randomized crossover study. The concentrations of gatifloxacin were determined by HPLC method.RESULTS The main pharmacokinetics of the two products were as following: AUC 0~36 (31.60±5.45) and (30.37±5.74) μg·h·mL -1 , c max (3.32±0.55) and (3.37±0.50) μg·mL -1 , t max (1.65±0.37) and (1.55±0.46) h,respectively.The relative bioavailability of domestic capsules to imported tablets was (104.6± 8.6 )%.CONCLUSION There were no significant difference between the parameters of the two preparations( P 0.05).The results demonstrated that the two preparations were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To observe the bioavailability of domestic gatifloxacin capsules and imported tablets.METHOD A single oral dose of 400 mg domestic capsules or imported tablets were given to 20 healthy volunteers in a randomized crossover study. The concentrations of gatifloxacin were determined by HPLC method.RESULTS The main pharmacokinetics of the two products were as following: AUC 0~36 (31.60±5.45) and (30.37±5.74) μg·h·mL -1 , c max (3.32±0.55) and (3.37±0.50) μg·mL -1 , t max (1.65±0.37) and (1.55±0.46) h,respectively.The relative bioavailability of domestic capsules to imported tablets was (104.6± 8.6 )%.CONCLUSION There were no significant difference between the parameters of the two preparations( P 0.05).The results demonstrated that the two preparations were bioequivalent.

Key concepts: Bioequivalence, Bioavailability, Gatifloxacin, Pharmacokinetics, Crossover study, Pharmacology, Significant difference, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Studies on the pharmacokinetics and bioequivalence of domestic gatifloxacin capsules in healthy volunteers — Research Paper | ScholarLens